Rechallenge therapy versus tyrosine kinase inhibitor (TKI) for advanced metastatic colorectal cancer: a retrospective study

Rechallenge therapy versus tyrosine kinase inhibitor (TKI) for advanced metastatic colorectal cancer: a retrospective study

Abstract Currently, the standard third-line treatment options for advanced metastatic colorectal cancer (mCRC) include regorafenib, fruquintinib, and trifluridine/tipiracil (TAS-102), but these drugs have limited clinical efficacy. This study aims to evaluate the efficacy and survival outcomes of ty...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chenming Liu, Jintao Chen, Yuxing Liu
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-02-01
Series:	Scientific Reports
Subjects:	Tyrosine kinase inhibitor Rechallenge therapy Metastatic colorectal cancer Overall survival Progression-free survival Propensity score matching
Online Access:	https://doi.org/10.1038/s41598-025-86575-x
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort
by: Hilin Yildirim, et al.
Published: (2025-02-01)

Survival and risk factors for metastatic colorectal cancer patients with a history of prior malignancy
by: Yiwen Qiu, et al.
Published: (2025-02-01)

Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settings
by: Armen Aprikian, et al.
Published: (2025-02-01)

The prognostic value of circulating tumor DNA in malignant melanoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
by: Lei Liu, et al.
Published: (2025-01-01)

Ocular adnexal lymphoma – A single-center observational study of survival outcomes
by: Karuvel Kannan Saraswathi, et al.
Published: (2025-02-01)

Tumor characteristics and survival rate of axillary metastatic breast cancer patients: a three decades retrospective cohort study
by: Seyed Mohamad Sadegh Mousavi-kiasary, et al.
Published: (2025-02-01)

Tyrosine Kinase-2, Angiopoietin-2, and Thrombomodulin Axes in the Late-Onset Fetal Growth Restriction: A Prospective Cohort Study
by: Esra Altan Erbilen, et al.
Published: (2024-12-01)

Protein kinase inhibitors as targeted therapy for glioblastoma: a meta-analysis of randomized controlled clinical trials
by: José Pinto-Fraga, et al.
Published: (2025-02-01)

Evaluating the surgical and oncological outcomes of hepatic artery variations in minimally invasive pancreaticoduodenectomy: insights from 2023 data at a high-volume pancreatic center
by: Tianyu Li, et al.
Published: (2025-02-01)

Multiparameter body composition analysis on chest CT predicts clinical outcomes in resectable non-small cell lung cancer
by: Yilong Huang, et al.
Published: (2025-02-01)

Assessment of Ki-67 expression in cases of prostatic carcinoma and its correlation with clinical outcomes
by: Sumaira Siddiqui
Published: (2024-04-01)

Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer?
by: Tommaso Porcelli, et al.
Published: (2025-02-01)

The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute lymphoblastic leukemia
by: Xiaoxia Wu, et al.
Published: (2024-09-01)

An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors
by: Russell J. Schilder, et al.
Published: (2025-03-01)

Effect of “Time To Surgery” on the Endometrial Cancer Prognosis
by: Engin Celik, et al.
Published: (2022-03-01)

Effect of comorbidity classes on survival of patients with gastrointestinal tract cancer
by: Linna Gao, et al.
Published: (2025-02-01)

Breast cancers with neuroendocrine differentiation: Retrospective case studies series from a single institution based on the 2019 WHO classification
by: Youngkyung Jeon, et al.
Published: (2024-01-01)

Prognostic value of serum inflammatory markers in patients with esophageal squamous cell carcinoma undergoing surgery: a two-center retrospective cohort study
by: Yaqin Dong, et al.
Published: (2025-02-01)

Long term effectiveness of intraoperative radiotherapy given as a boost in adjuvant treatment for oral cavity cancers
by: Grzegorz Woźniak, et al.
Published: (2025-02-01)

Phase Ib/II study on the safety, tolerability, and preliminary efficacy of pegylated irinotecan (JK1201I) as second‐line monotherapy for patients with small‐cell lung cancer
by: Jieran Long, et al.
Published: (2024-09-01)

Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer
by: Maria Elena Lacruz, et al.
Published: (2025-02-01)

Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis
by: Yin-Che Wang, et al.
Published: (2025-12-01)

Employment status and women's fertility: Do working women have fewer children?
by: Yulmardi Yulmardi, et al.
Published: (2024-12-01)

Comparison of Survival Outcomes of Lymphovascular Space Invasion-Negative and Lymphovascular Space Invasion - Positive Women with Stage IIIC Endometrioid Endometrial Cancer: A Case - Control Study
by: Zeliha Firat Cuylan, et al.
Published: (2021-04-01)

Comparative effectiveness of laparoscopic versus open colectomy in colon cancer patients: a study protocol for emulating a target trial using cancer registry data
by: Semaw Ferede Abera, et al.
Published: (2025-01-01)

Dynamic monocyte changes as prognostic indicators in operable gastric cancer: a retrospective cohort analysis
by: Yiwei Jiang, et al.
Published: (2025-02-01)

El papel del agrupamiento escolar en las desigualdades educativas intrarregionales. Una extensión del «Propensity Score Matching» al análisis regional
by: Bruno Blanco-Varela, et al.
Published: (2024-07-01)

Las consecuencias económicas de un nombre atípico. El caso colombiano
by: Alejandro Gaviria, et al.
Published: (2010-01-01)

Prognostic Value of Inflammatory and Nutritional Indicators in Non-Metastatic Soft Tissue Sarcomas
by: Yan Y, et al.
Published: (2025-02-01)

A Bibliometric Analysis of Medullary Thyroid Carcinoma From 2000 to 2022
by: TAN Meijuan, et al.
Published: (2024-07-01)

Pulmonary Nuclear protein in Testis (NUT) carcinoma: clinical, molecular characteristics, and treatment strategies
by: Jingjing Qu, et al.
Published: (2025-02-01)

The correlation between the expression of androgen receptor splice variant-7 (AR-V7) protein with the time of occurrence of castration-resistant prostate cancer and overall survival in prostate cancer in Indonesian population
by: Indrawarman Soerohardjo, et al.
Published: (2025-02-01)

Oncological aid for colorectal cancer patients in Tomsk area: ways of cancer prevention
by: L. D. Zhuykova, et al.
Published: (2014-12-01)

Predictors of survival rates among breast cancer patients in Ethiopia: a systematic review and meta-analysis 2024
by: Chalie Mulugeta, et al.
Published: (2025-02-01)

Can the new model of shared property rights promote better corporate financial performance in China?
by: Zihao Ma, et al.
Published: (2025-02-01)

Infiltration of CD8+ cytotoxic T-cells and expression of PD-1 and PD-L1 in ovarian clear cell carcinoma
by: Mengdi Fu, et al.
Published: (2025-02-01)

HPK1 kinase inhibitor: a sufficient approach to target HPK1 to modulate T cell activation in cancer immunotherapy compared with degraders
by: Qin Wang, et al.
Published: (2025-02-01)

Sedentary Behavior and Its Association With Psychological Well-Being and Sleep Quality in Adolescents: Evidence from a Propensity Score Analysis
by: Zhang L, et al.
Published: (2025-02-01)

Pediatric and adolescent chronic myeloid leukemia: A follow-up study in Western India
by: Sangita A. Vanik, et al.
Published: (2023-07-01)

Surgical management of metastatic lesions in the proximal femur: a systematic review
by: Afrim Iljazi, et al.
Published: (2025-02-01)